ArticleCurrent medical imaging2025
Preliminary Study on the Evaluation Value of Extracellular Volume Fraction in the Pathological Grading of Lung Invasive Adenocarcinoma
Article in Current medical imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Application value of CT-based extracellular volume fraction in assessing microsatellite status in colorectal cancer.American journal of translational research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThis study aims to evaluate the diagnostic value of extracellular volume fraction (ECV) and spectral CT parameters in assessing the pathological grading of lung invasive adenocarcinoma (IAC) presenting as solid or subsolid nodules.
methodsA retrospective collection of patients who were pathologically confirmed as IAC with solid or subsolid pulmonary nodules at our hospital from March 2023 to November 2024 was conducted. Relevant data were recorded, and the patients were divided into two groups: intermediate/high differentiation and low differentiation. The parameters including arterial phase iodine concentration (IC
resultsA total of 61 patients were included, comprising 40 in the intermediate to high differentiation group and 21 in the low differentiation group. The intermediate/high differentiation group had higher values of ECV DISCUSSION: ECVV outperforms other spectral parameters in differentiating IAC grades, reflecting changes in the tumor microenvironment. Combining ECV
conclusionExtracellular volume fraction can provide more information for the pathological grading assessment of invasive adenocarcinoma of the lung. Compared to other spectral parameters, ECV
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.